Figure 2.
Clinical outcomes for entire cohort (N=120). (A) Cumulative incidence of non-relapse mortality (NRM) and relapse; (B) acute graft-versus-host disease (aGvHD) grades 2-4 and grades 3-4; (C) chronic GvHD (cGVHD) all grade and cGvHD requiring systemic immunosuppression; and (D) Kaplan Meier estimates of overall survival (OS) and progression-free survival (PFS). Gr: grade; Req. system: requiring systemic immunosuppression; Relap: relapse.
